Vlado Bosanac is estimated to have a net worth in the range of $2 million to $8 million USD, with a best-supported figure of approximately $4 million to $5 million. That range reflects his career as a co-founder and long-serving CEO of Advanced Human Imaging (ASX: AHI), a publicly listed health-tech company, combined with roughly three decades of capital markets and corporate advisory work. Because he operates through a publicly listed entity, some financial information is accessible via regulatory filings, but personal net worth still requires estimation rather than direct confirmation.
Vlado Bosanac Net Worth: Estimate, Sources, and Methodology
Marko Beograd
16 May 2026
Which Vlado Bosanac this is about
The name Vlado Bosanac is not especially common, but it is worth confirming which individual this article addresses. The Vlado Bosanac behind this search is a business executive and entrepreneur, identified across multiple credible public sources as the CEO, Co-Founder, and at various points Executive Chairman of Advanced Human Imaging Limited, a health-technology company listed on the Australian Securities Exchange. A PR Newswire release from February 2022 explicitly names him as "CEO and Chairman" in the context of a leadership transition. SEC filings for the company's related US entity also list him as founder and CEO. An ASX annual report further identifies him as "Executive Director and Chief Executive Officer." His background spans over 29 years in capital markets, deal origination, leveraged and management buyouts, and corporate advisory roles, according to podcast and investor-relations materials tied to the company.
This is the figure who anchors the "vlado bosanac net worth" search. He is not a politician, athlete, or entertainer, which puts him in a slightly different category from some other Balkan and Eastern European public figures tracked on this site, such as Vlado Saric or Bora Djordjevic, whose wealth is tied to criminal enterprise allegations or music careers respectively. Bosanac's wealth is tied to the corporate and capital markets world, which means the estimation methodology and the sources you would consult are different.
Why the numbers you find online will differ
Net worth figures for private individuals and even many public company executives are estimates, not audited facts. A company can be publicly listed and still tell you very little about what its founder personally owns, owes, or earns outside of that company. What you can find in public filings are things like director remuneration disclosures, share ownership registers, and related-party transactions. What you cannot find directly is the executive's mortgage balance, private investment portfolio, or personal liabilities. That gap is where estimation comes in, and it is why you will see wildly different figures on different websites.
Automated net worth aggregator sites often pull a single data point, usually share ownership value at a given date, and present it as a net worth figure with false precision. The problem is that share prices move, directors sell or acquire shares, and the company's market cap at any given moment may not reflect intrinsic value. For a company like Advanced Human Imaging, which has gone through leadership transitions and market fluctuations typical of small-cap health-tech listings, this creates significant volatility in any share-based estimate. Always treat a single number from an aggregator site as a rough proxy, not a confirmed figure.
The net worth estimate: range and best-supported figure
Working from what is publicly verifiable, the most defensible estimate for Vlado Bosanac's net worth sits between $2 million and $8 million USD, with the midpoint range of $4 million to $5 million being the most plausible single-band estimate as of mid-2026. Here is how that range is constructed:
- Founder equity stake in Advanced Human Imaging: As a co-founder and long-serving CEO, Bosanac would typically hold a meaningful equity position in the company. AHI is a small-cap ASX-listed company, meaning his stake, while potentially significant in percentage terms, translates to a dollar figure that is sensitive to market conditions. At various points in AHI's trading history, a founder-level stake could represent anywhere from under $1 million to several million dollars depending on share price and dilution.
- Career earnings from capital markets and advisory work: With nearly three decades in capital markets, deal origination, and corporate advisory roles, accumulated savings and investment income represent a material component of personal wealth beyond any single equity position.
- Post-CEO transition income: Following the February 2022 leadership transition in which he moved to a Head of Strategy and Revenue Growth role, his direct compensation structure likely changed, which affects ongoing income flows.
- Personal investments and assets: Standard for an individual with this career profile, personal real estate and financial investments are probable but unconfirmed.
The lower end of the range ($2 million) accounts for scenarios where AHI's market cap has contracted significantly, his personal equity stake has been diluted or partially liquidated, and career earnings have been offset by business costs or personal liabilities. The upper end ($8 million) reflects a scenario where founder equity retains value, career earnings have compounded well, and real estate or other assets add meaningful weight. The $4 million to $5 million midpoint is the most defensible single estimate given the available evidence and the typical financial profile of a founder-CEO at a small-cap listed health-tech company operating in this market segment.
Where the wealth likely comes from
Founder equity in Advanced Human Imaging
The most visible and most variable component of Bosanac's estimated wealth is his equity position in AHI. As a co-founder and CEO, he would have received a founder's share allocation at or near the company's inception. Over time, this stake is subject to dilution through capital raises (common for growth-stage listed companies), vesting schedules, and any shares he may have sold. ASX-listed companies are required to disclose director shareholdings in annual reports and through change-of-interest notices, so this is one area where some transparency exists, though it requires reading through filings directly.
Capital markets and corporate advisory career
Before and alongside his AHI role, Bosanac's career encompasses capital markets, leveraged buyout (LBO) and management buyout (MBO) advisory, deal origination, and project implementation across what appears to be a multi-decade span in financial services. This kind of career, spanning close to three decades at a senior level, typically generates substantial cumulative compensation, deal success fees, and investment co-participation rights. These earnings would form the foundation of personal wealth independent of any single company.
Executive compensation at AHI
As CEO of a publicly listed company, Bosanac would have received executive remuneration, which in Australian-listed companies is disclosed in the annual report's remuneration report section. For small-cap ASX companies, CEO salaries typically range from AUD $150,000 to $500,000 per year depending on the company's size and stage, though some early-stage founders take reduced salaries in exchange for equity. Following his transition to Head of Strategy and Revenue Growth in 2022, his compensation structure may have adjusted downward from a CEO-level package.
Assets and liabilities: what can be inferred
Specific asset details for Vlado Bosanac are not publicly documented in any source reviewed for this article. What can be reasonably inferred from his career profile is the following, with the important caveat that none of this is confirmed:
| Asset / Liability Category | Status | Notes |
|---|---|---|
| AHI founder equity stake | Probable, value variable | Disclosable via ASX director interest notices and annual reports |
| Real estate holdings | Probable but unconfirmed | Typical for executives at this career level; jurisdiction unknown |
| Private investment portfolio | Possible | Career in capital markets suggests financial market familiarity; no public evidence |
| Business interests beyond AHI | Possible | Advisory and deal-origination background may include co-investment stakes |
| Liabilities (mortgages, business loans) | Unknown | No public disclosure available; standard for private individuals |
One important consideration for any Balkan or Eastern European-origin business figure operating in international capital markets is that assets may be spread across multiple jurisdictions. This makes estimation harder and means any single-country property search would give an incomplete picture. Without confirmed details, these remain inferences based on career profile rather than documented facts.
How these estimates are built and how to judge the reliability of sources
The estimate in this article draws on four categories of evidence, listed here in descending order of reliability:
- Regulatory filings: SEC EDGAR filings and ASX annual reports are the most reliable sources because they are legally required disclosures. They confirm role, tenure, share ownership, and remuneration ranges. They do not confirm total personal net worth.
- Corporate announcements via PR Newswire and company newsfeeds: These confirm role transitions, company milestones, and public statements. Useful for understanding career trajectory and organizational standing.
- Podcast and investor-relations materials: These provide career summaries and background. Less rigorous than filings but useful for confirming stated experience and positioning.
- Industry benchmarking: Comparing executive compensation and founder equity values at comparable small-cap ASX health-tech companies helps anchor a plausible range when specific figures are unavailable.
When you evaluate a net worth figure from any source, ask three questions: How old is the estimate? Share prices and business valuations move constantly, so a figure from two or three years ago may be substantially wrong today. What is it based on? A source that explains its methodology is more trustworthy than one that presents a round number with no context. Is it specific to the right person? Name confusion is a real problem, especially for individuals with Balkan surnames that may be shared across the region.
What to check next if you want to dig deeper
If you want to verify or refine this estimate yourself, here are the most productive next steps:
- Search ASX company announcements for Advanced Human Imaging Limited (ASX: AHI): Look for director interest notices (which disclose share acquisitions and disposals) and the annual report's remuneration report section. These are free to access via the ASX website.
- Search SEC EDGAR for Advanced Health Intelligence or Advanced Human Imaging: The US entity filings may include additional disclosures about the founder's role and equity position under US securities law requirements.
- Check AHI's current share price and market cap: Calculate the approximate value of any disclosed founder stake against today's price to get a current equity-based estimate.
- Review the PR Newswire announcement from February 2022: This confirms the leadership transition and any changes to his role, which affects ongoing income and equity vesting assumptions.
- Look for any Australian company registry filings: ASIC (Australian Securities and Investments Commission) records may show any related companies he directs, which could indicate additional business interests.
- Cross-reference with credible financial journalism: Search for any reporting in Australian financial media (such as AFR, The Australian, or ASX-focused investment publications) that covers AHI and mentions Bosanac directly.
The bottom line is that Vlado Bosanac's estimated net worth of $4 million to $5 million (within a $2 million to $8 million range) is a reasonable, evidence-anchored estimate for a career capital markets professional and co-founder of a publicly listed health-tech company. If you are trying to estimate Bora Djordjevic net worth, you would typically rely on similar public filing signals and understand the difference between market-based proxies and confirmed personal assets. It is not a confirmed figure, and it will shift as AHI's share price moves and as his personal financial situation evolves. If you are specifically searching for Vlado Bosanac's romir bosu net worth, remember this range is still an estimate rather than a confirmed figure. You can also compare this range with other reporting on Bora Milutinovic net worth to see how methodologies differ across sources. Use it as a starting point and apply the verification steps above if you need a more current or more precise assessment. As with other executives and public figures covered on this site, the estimate is a research tool, not a definitive accounting. If you are specifically looking for René Bosne net worth, you should expect the same kind of estimation methodology and the same limits of what is publicly confirmable.
FAQ
Can his net worth be confirmed with publicly available documents?
In this case, you cannot reliably “confirm” a single personal net worth number from filings alone. Public disclosures typically cover director remuneration and disclosed shareholdings, but they do not list private mortgages, other investment accounts, tax liabilities, or non-public real estate. So even if share ownership is disclosed, the final net worth still depends on assumptions about what he sold, what he still holds, and what private assets or debts exist.
Why do net worth numbers swing so much on different websites?
Use a share-based estimate only as a proxy, and update it with the specific cut-off date. Share price changes, dilution from raises, and director sales can swing the implied value quickly. A better approach is to bracket it, for example, multiply his disclosed share count by both the current market price and a historical price window, then adjust for typical dilution over time.
What filings should I check to refine the estimate (and what should I avoid)?
Start with the annual report director share table, then check for any change-of-interest notices that show purchases or sales. If his role changed over time, his compensation structure may have shifted too, so use the correct remuneration period rather than assuming the same CEO package throughout. This reduces the risk of using stale or mismatched data.
How can I tell if a net worth figure is just an automated guess?
If you see an “exact” figure, treat it as unreliable unless the source explains its methodology. Many aggregators effectively take one snapshot, such as share value at one date, and present it as net worth with no allowance for liabilities or the possibility that shares are subject to sale restrictions or have already been partially sold.
How do I avoid mixing up the wrong Vlado Bosanac?
Name confusion is a real issue with the “Vlado Bosanac” search term. Before you use any number, verify that the person matches the specific company and role context (Advanced Human Imaging, listed on the ASX, CEO/co-founder/executive director). Cross-check at least two independent identifiers such as job title and employer, not just the name.
Does Advanced Human Imaging’s market cap directly equal his net worth?
A company’s market capitalization affects the implied value of his equity stake, but it does not capture personal liquidity. Net worth can remain flat even when market cap moves if his shares are held and not sold, and it can also rise without dramatic market cap changes if he has other assets. That is why equity value should be combined with career compensation signals and any disclosed share disposals to bracket outcomes.
What are the biggest modeling mistakes when estimating a founder’s stake?
One common mistake is ignoring dilution. For growth-stage listed companies, capital raises can reduce the percentage ownership of founders even if their absolute share count changes. Another mistake is not accounting for partial sell-downs around liquidity events, which breaks the link between current market price and original founder allocation.
How can I do a fast sanity check on whether an estimated net worth is plausible?
If you want a quick personal-stake sanity check, look for whether director shareholdings show a long-term holding pattern versus frequent changes, then compare that against the company’s major financing events. If shareholdings stay relatively stable across multiple years, large volatility in an “instant net worth” claim is likely exaggerated.
If I want the most up-to-date range, how should I update the estimate?
The article’s midpoint is framed as a reasonable band, not an accounting figure. A practical way to update it is to re-run the equity component using the latest disclosed share count and the latest share price, then keep the same liability uncertainty range (since debts and private assets are not fully disclosed). If the implied equity value shifts dramatically beyond the existing band, widen your range rather than forcing a single “new” number.